Beryl Drugs Limited (BOM:524606)
25.46
+0.94 (3.83%)
At close: Apr 17, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 129.13 million as of April 17, 2026. Its market cap has increased by 6.80% in one year.
Market Cap
129.13M
Enterprise Value
171.47M
Revenue
176.65M
Ranking
n/a
PE Ratio
915.78
Stock Price
25.46
Market Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 129.13M, an increase of 3,395.24%. That is a compound annual growth rate of 18.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 124.36M | 4.79% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hamps Bio | 191.66M |
| Zenith Healthcare | 176.80M |
| Norris Medicines | 142.51M |
| Desh Rakshak Aushdhalaya | 139.89M |
| Emmessar Biotech & Nutrition | 134.84M |
| Colinz Laboratories | 120.41M |
| Shamrock Industrial Company | 115.99M |
| Ortin Global | 111.48M |